Wizard Wellness, Inc – Trademark Portfolio
Entity Type: 03
Wizard Wellness, Inc holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. Currently, 1 trademark is registered and 9 are pending. Notable registered marks include ALLERGY ALCHEMY. The owner is based in Orinda, CA.
20 Camino Sobrante
Orinda, CA 94563
Showing of trademarks Trademarks
Trademark Classifications
Wizard Wellness, Inc's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Wizard Wellness, Inc have?
Wizard Wellness, Inc has 12 U.S. trademarks filed with the USPTO. Of these, 1 registered, 9 pending, 2 abandoned.
What trademark classes does Wizard Wellness, Inc file in?
Wizard Wellness, Inc files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Wizard Wellness, Inc's most well-known trademarks?
Wizard Wellness, Inc's registered trademark portfolio includes well-known marks such as ALLERGY ALCHEMY. These are among 1 currently registered trademark in the portfolio.
What is Wizard Wellness, Inc's trademark registration success rate?
Wizard Wellness, Inc has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 9 applications are pending review.